THE EFFECTS OF ETANERCEPT AND CABERGOLINE ON ENDOMETRIOTIC IMPLANTS, UTERUS AND OVARIES IN RAT ENDOMETRIOSIS MODEL

Cihan Deniz Keleş,Birol Vural,Serdar Filiz,Fisun Vural,Gülçin Gacar,Fatma Ceyla Eraldemir,Sema Kurnaz

Journal of Reproductive Immunology（2021）

引用 0|浏览3

暂无评分

摘要

•Etanercept and/or cabergoline decreased volume of ectopic endometrial implants.•Etanercept and/or cabergoline decreased TNF-α and VEGF staining of ectopic endometrial implants.•Etanercept and/or Cabergoline decreased endometrial MSC-like cells of ectopic implants.•Etanercept and Etanercept + Cabergoline decreased TNF-α staining of the ovaries.•Etanercept + Cabergoline treatment increased peripheral blood CD25+ & CD5+ Cells.

查看译文

关键词

AFC,AMH,Cb,CD2,CD4,CD5,CD8a,CD25,CD45,CD146,Co,DRD2-A,E,ELISA,FITC,H&E,IHC,IL-6,IL-10,IL-13,IL-37,mTOR,NGF,PDGFR-Rβ,PE,PTPRC,Sh,TNF-α,Treg,VEGF

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要